G2GBIO financial statements
지투지바이오KRX:456160 · KOSDAQ₩44,700+1.82%
2026-10-07 closeG2GBIO's 2025 annual results accompany close-price data dated 2026-10-07. 2025 revenue was KRW 423.07M. 2025 operating profit was −KRW 12.2B.
Reported results
Quantus Signal · live data · not investment advice · Privacy Policy